| ONECUT2 is a driver of neuroendocrine prostate cancer H Guo, X Ci, M Ahmed, JT Hua, F Soares, D Lin, L Puca, A Vosoughi, ... Nature communications 10 (1), 278, 2019 | 189 | 2019 |
| The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer F Crea, E Venalainen, X Ci, H Cheng, L Pikor, A Parolia, H Xue, ... Epigenomics 8 (5), 721-731, 2016 | 116 | 2016 |
| N6-methyladenosine reader YTHDF1 promotes ARHGEF2 translation and RhoA signaling in colorectal cancer S Wang, S Gao, Y Zeng, L Zhu, Y Mo, CC Wong, Y Bao, P Su, J Zhai, ... Gastroenterology 162 (4), 1183-1196, 2022 | 97 | 2022 |
| KLF5 activates microRNA 200 transcription to maintain epithelial characteristics and prevent induced epithelial-mesenchymal transition in epithelial cells B Zhang, Z Zhang, S Xia, C Xing, X Ci, X Li, R Zhao, S Tian, G Ma, Z Zhu, ... Molecular and cellular biology 33 (24), 4919-4935, 2013 | 94 | 2013 |
| Molecular events in neuroendocrine prostate cancer development Y Wang, Y Wang, X Ci, SYC Choi, F Crea, D Lin, Y Wang Nature Reviews Urology 18 (10), 581-596, 2021 | 82 | 2021 |
| Targeting MCT 4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer SYC Choi, SL Ettinger, D Lin, H Xue, X Ci, N Nabavi, RH Bell, F Mo, ... Cancer medicine 7 (7), 3385-3392, 2018 | 66 | 2018 |
| Heterochromatin protein 1α mediates development and aggressiveness of neuroendocrine prostate cancer X Ci, J Hao, X Dong, SY Choi, H Xue, R Wu, S Qu, PW Gout, F Zhang, ... Cancer research 78 (10), 2691-2704, 2018 | 54 | 2018 |
| Interruption of KLF5 acetylation converts its function from tumor suppressor to tumor promoter in prostate cancer cells X Li, B Zhang, Q Wu, X Ci, R Zhao, Z Zhang, S Xia, D Su, J Chen, G Ma, ... International journal of cancer 136 (3), 536-546, 2015 | 54 | 2015 |
| KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation X Ci, C Xing, B Zhang, Z Zhang, JJ Ni, W Zhou, JT Dong Molecular cancer 14, 1-15, 2015 | 42 | 2015 |
| Transforming growth factor β inhibits platelet derived growth factor-induced vascular smooth muscle cell proliferation via Akt-independent, Smad-mediated cyclin D1 downregulation A Martin-Garrido, HC Williams, M Lee, B Seidel-Rogol, X Ci, JT Dong, ... PLoS One 8 (11), e79657, 2013 | 38 | 2013 |
| A synopsis of prostate organoid methodologies, applications, and limitations AM Gleave, X Ci, D Lin, Y Wang The Prostate 80 (6), 518-526, 2020 | 36 | 2020 |
| Klf5 acetylation regulates luminal differentiation of basal progenitors in prostate development and regeneration B Zhang, X Ci, R Tao, JJ Ni, X Xuan, JL King, S Xia, Y Li, HF Frierson, ... Nature communications 11 (1), 997, 2020 | 32 | 2020 |
| Klf5 Deletion Promotes Pten Deletion–Initiated Luminal-Type Mouse Prostate Tumors through Multiple Oncogenic Signaling Pathways C Xing, X Ci, X Sun, X Fu, Z Zhang, EN Dong, ZZ Hao, JT Dong Neoplasia 16 (11), 883-899, 2014 | 30 | 2014 |
| Treatment-emergent neuroendocrine prostate cancer: molecularly driven clinical guidelines PL Clermont, X Ci, H Pandha, Y Wang, F Crea International Journal of Endocrine Oncology 6 (2), IJE20, 2019 | 29 | 2019 |
| The evolutionarily conserved long non‐coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and … RL Mather, A Parolia, SE Carson, E Venalainen, D Roig‐Carles, M Jaber, ... Molecular oncology 15 (7), 1921-1941, 2021 | 23 | 2021 |
| KLF5 is crucial for androgen-AR signaling to transactivate genes and promote cell proliferation in prostate cancer cells J Li, B Zhang, M Liu, X Fu, X Ci, C Fu, G Dong, R Wu, Z Zhang, L Fu, ... Cancers 12 (3), 748, 2020 | 21 | 2020 |
| Patient-derived hormone-naive prostate cancer xenograft models reveal growth factor receptor bound protein 10 as an androgen receptor-repressed gene driving the development of … J Hao, X Ci, H Xue, R Wu, X Dong, SYC Choi, H He, Y Wang, F Zhang, ... European urology 73 (6), 949-960, 2018 | 21 | 2018 |
| CINP is a novel cofactor of KLF5 required for its role in the promotion of cell proliferation, survival and tumor growth Q Wu, C Fu, M Li, J Li, Z Li, L Qi, X Ci, G Ma, A Gao, X Fu, N An, M Liu, ... International journal of cancer 144 (3), 582-594, 2019 | 18 | 2019 |
| Immune phenotypes of prostate cancer cells: Evidence of epithelial immune cell-like transition? D Lin, X Wang, SYC Choi, X Ci, X Dong, Y Wang Asian journal of urology 3 (4), 195-202, 2016 | 18 | 2016 |
| Conditionally reprogrammed cells from patient-derived xenograft to model neuroendocrine prostate cancer development X Ci, J Hao, X Dong, H Xue, R Wu, SYC Choi, AM Haegert, CC Collins, ... Cells 9 (6), 1398, 2020 | 17 | 2020 |
